Neurovascular Devices – Market Insights – United States

The US neurovascular device market will see moderate growth through 2032 driven by the growing adoption of thrombectomy for managing acute ischemic stroke, the launch of new embolization and thrombectomy devices that treat expanded indications, as well as the continued expansion of infrastructure dedicated to facilitating neurovascular interventions.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for stroke devices in the US from 2019 through 2032.

The COVID-19 pandemic had a relatively limited impact on the US neurovascular device market.

How did the impact of the COVID-19 pandemic vary across different neurovascular device segments?

How quickly have procedure volumes, sales, and revenues recovered?

Flow-diverting devices and liquid embolics are contributing to growth in the neurovascular embolization device market.

How will adoption of flow-diverting devices impact the neurovascular embolization coil and coiling-assist device markets?

Which strategies are competitors adopting to gain a competitive edge over other competitors in the flow-diverting device market?

How has the competitive landscape changed with the emergence of new competitors and products?

The thrombectomy device market is highly dynamic.

What impact is recent clinical data having on thrombectomy device use?

How will the launch of new technologies in the thrombectomy device market influence adoption of thrombectomy for AIS?

For which indications have products been approved?

Table of contents